The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.
The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.